← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2013Last known activity
Apr 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (9)
- NCT06368726Lead sponsorPhase 1Apr 1, 2024
- NCT04850703Lead sponsorPhase 1/Phase 2Feb 2, 2021
- NCT04850703CollaboratorPhase 1/Phase 2Feb 2, 2021
- NCT04850703CollaboratorPhase 1/Phase 2Feb 2, 2021
- NCT04850703Sponsor investigatorPhase 1/Phase 2Feb 2, 2021
- NCT02614599Overall official - principal investigatorEarly Phase 1Jun 1, 2015
- NCT02614599Lead sponsorEarly Phase 1Jun 1, 2015
- NCT01856686Lead sponsorEarly Phase 1Dec 1, 2013
- NCT01856686Overall official - principal investigatorEarly Phase 1Dec 1, 2013
Details
- Last known activity
- Apr 1, 2024